Item Type | Name |
Academic Article
|
Targeting of functional antibody-decay-accelerating factor fusion proteins to a cell surface.
|
Academic Article
|
A tumor-expressed inhibitor of the early but not late complement lytic pathway enhances tumor growth in a rat model of human breast cancer.
|
Academic Article
|
Complement receptor 2-mediated targeting of complement inhibitors to sites of complement activation.
|
Academic Article
|
Complement function in mAb-mediated cancer immunotherapy.
|
Academic Article
|
Mouse complement receptor-related gene y/p65-neutralized tumor vaccine induces antitumor activity in vivo.
|
Academic Article
|
Complement inhibitors targeted to the proximal tubule prevent injury in experimental nephrotic syndrome and demonstrate a key role for C5b-9.
|
Academic Article
|
Insights into the human CD59 complement binding interface toward engineering new therapeutics.
|
Academic Article
|
Combined therapeutic use of AdGFPFasL and small molecule inhibitors of ceramide metabolism in prostate and head and neck cancers: a status report.
|
Academic Article
|
Complement plays an important role in spinal cord injury and represents a therapeutic target for improving recovery following trauma.
|
Academic Article
|
A novel targeted inhibitor of the alternative pathway of complement and its therapeutic application in ischemia/reperfusion injury.
|
Academic Article
|
App1: an antiphagocytic protein that binds to complement receptors 3 and 2.
|
Academic Article
|
A targeted inhibitor of the alternative complement pathway reduces angiogenesis in a mouse model of age-related macular degeneration.
|
Academic Article
|
A complement-dependent balance between hepatic ischemia/reperfusion injury and liver regeneration in mice.
|
Academic Article
|
Complement-dependent inflammation and injury in a murine model of brain dead donor hearts.
|
Academic Article
|
Targeted inhibition of the complement alternative pathway with complement receptor 2 and factor H attenuates collagen antibody-induced arthritis in mice.
|
Academic Article
|
Macrophage-produced IL-12p70 mediates hemorrhage-induced damage in a complement-dependent manner.
|
Academic Article
|
A targeted inhibitor of the complement alternative pathway reduces RPE injury and angiogenesis in models of age-related macular degeneration.
|
Academic Article
|
Complement regulates TLR4-mediated inflammatory responses during intestinal ischemia reperfusion.
|
Academic Article
|
The alternative and terminal pathways of complement mediate post-traumatic spinal cord inflammation and injury.
|
Academic Article
|
The alternative pathway is required, but not alone sufficient, for retinal pathology in mouse laser-induced choroidal neovascularization.
|
Academic Article
|
Complement inhibition alleviates paraquat-induced acute lung injury.
|
Academic Article
|
CD4+ T cells and complement independently mediate graft ischemia in the rejection of mouse orthotopic tracheal transplants.
|
Academic Article
|
The dual role of complement in the progression of renal disease in NZB/W F(1) mice and alternative pathway inhibition.
|
Academic Article
|
A targeted complement-dependent strategy to improve the outcome of mAb therapy, and characterization in a murine model of metastatic cancer.
|
Academic Article
|
Oval cell response is attenuated by depletion of liver resident macrophages in the 2-AAF/partial hepatectomy rat.
|
Academic Article
|
The C5 convertase is not required for activation of the terminal complement pathway in murine experimental cerebral malaria.
|
Academic Article
|
The alternative complement pathway propagates inflammation and injury in murine ischemic stroke.
|
Academic Article
|
Targeting complement component 5a promotes vascular integrity and limits airway remodeling.
|
Academic Article
|
Upregulation of the d opioid receptor in liver cancer promotes liver cancer progression both in vitro and in vivo.
|
Academic Article
|
The effect of dexamethasone on human mucin 1 expression and antibody-dependent complement sensitivity in a prostate cancer cell line in vitro and in vivo.
|
Academic Article
|
A novel murine P-450 gene, Cyp4a14, is part of a cluster of Cyp4a and Cyp4b, but not of CYP4F, genes in mouse and humans.
|
Academic Article
|
Inhibition of a complement regulator in vivo enhances antibody therapy in a model of mammary adenocarcinoma.
|
Academic Article
|
Targeted complement inhibition by C3d recognition ameliorates tissue injury without apparent increase in susceptibility to infection.
|
Academic Article
|
Complement-mediated mechanisms in anti-GD2 monoclonal antibody therapy of murine metastatic cancer.
|
Academic Article
|
Interference with the complement system by tumor cell membrane type-1 matrix metalloproteinase plays a significant role in promoting metastasis in mice.
|
Academic Article
|
Complement-dependent P-selectin expression and injury following ischemic stroke.
|
Academic Article
|
Enhancement of antibody-dependent mechanisms of tumor cell lysis by a targeted activator of complement.
|
Academic Article
|
A complement C3 inhibitor specifically targeted to sites of complement activation effectively ameliorates collagen-induced arthritis in DBA/1J mice.
|
Academic Article
|
Low-dose targeted complement inhibition protects against renal disease and other manifestations of autoimmune disease in MRL/lpr mice.
|
Academic Article
|
Effects of active and inactive phospholipase D2 on signal transduction, adhesion, migration, invasion, and metastasis in EL4 lymphoma cells.
|
Academic Article
|
Modulation of protective T cell immunity by complement inhibitor expression on tumor cells.
|
Academic Article
|
A role for complement in the enhanced susceptibility of steatotic livers to ischemia and reperfusion injury.
|
Academic Article
|
Ketamine-xylazine-acepromazine compared with isoflurane for anesthesia during liver transplantation in rodents.
|
Academic Article
|
A new therapeutic strategy for lung tissue injury induced by influenza with CR2 targeting complement inhibitor.
|
Academic Article
|
Targeted inhibition of complement activation prevents features of preeclampsia in mice.
|
Academic Article
|
Targeted complement inhibitors protect against posttransplant cardiac ischemia and reperfusion injury and reveal an important role for the alternative pathway of complement activation.
|
Academic Article
|
The benefit of targeted and selective inhibition of the alternative complement pathway for modulating autoimmunity and renal disease in MRL/lpr mice.
|
Academic Article
|
Mapping the intermedilysin-human CD59 receptor interface reveals a deep correspondence with the binding site on CD59 for complement binding proteins C8alpha and C9.
|
Academic Article
|
Binding of factor H to tubular epithelial cells limits interstitial complement activation in ischemic injury.
|
Academic Article
|
Complement and the alternative pathway play an important role in LPS/D-GalN-induced fulminant hepatic failure.
|
Academic Article
|
The critical role of complement alternative pathway regulator factor H in allergen-induced airway hyperresponsiveness and inflammation.
|
Academic Article
|
Pathogenic natural antibodies propagate cerebral injury following ischemic stroke in mice.
|
Academic Article
|
Complement-dependent injury and protection in a murine model of acute dextran sulfate sodium-induced colitis.
|
Academic Article
|
A new treatment for neurogenic inflammation caused by EV71 with CR2-targeted complement inhibitor.
|
Academic Article
|
CR2-mediated targeting of complement inhibitors: bench-to-bedside using a novel strategy for site-specific complement modulation.
|
Academic Article
|
Donor brain death exacerbates complement-dependent ischemia/reperfusion injury in transplanted hearts.
|
Academic Article
|
Inhibition of complement activation alleviates acute lung injury induced by highly pathogenic avian influenza H5N1 virus infection.
|
Academic Article
|
Essential roles of grp94 in gut homeostasis via chaperoning canonical Wnt pathway.
|
Concept
|
Disease Models, Animal
|
Concept
|
Animals, Newborn
|
Concept
|
Animals
|
Concept
|
Mammary Neoplasms, Animal
|
Concept
|
Physical Conditioning, Animal
|
Concept
|
Models, Animal
|
Academic Article
|
Targeted inhibition of complement using complement receptor 2-conjugated inhibitors attenuates EAE.
|
Academic Article
|
The complement regulatory protein CD59: insights into attenuation of choroidal neovascularization.
|
Academic Article
|
Targeted mouse complement inhibitor CR2-Crry protects against the development of atherosclerosis in mice.
|
Academic Article
|
A novel protocol allowing oral delivery of a protein complement inhibitor that subsequently targets to inflamed colon mucosa and ameliorates murine colitis.
|
Academic Article
|
Complement-dependent modulation of antitumor immunity following radiation therapy.
|
Academic Article
|
Dissecting the complement pathway in hepatic injury and regeneration with a novel protective strategy.
|
Academic Article
|
Reduction of myeloid-derived suppressor cells and lymphoma growth by a natural triterpenoid.
|
Academic Article
|
New therapeutic and diagnostic opportunities for injured tissue-specific targeting of complement inhibitors and imaging modalities.
|
Academic Article
|
A Targeted Inhibitor of the Alternative Complement Pathway Accelerates Recovery From Smoke-Induced Ocular Injury.
|
Academic Article
|
Modulation of post-stroke degenerative and regenerative processes and subacute protection by site-targeted inhibition of the alternative pathway of complement.
|
Academic Article
|
IL-1a and complement cooperate in triggering local neutrophilic inflammation in response to adenovirus and eliminating virus-containing cells.
|
Academic Article
|
Regulation of the alternative pathway of complement modulates injury and immunity in a chronic model of dextran sulphate sodium-induced colitis.
|
Academic Article
|
A new mouse anti-mouse complement receptor type 2 and 1 (CR2/CR1) monoclonal antibody as a tool to study receptor involvement in chronic models of immune responses and disease.
|
Academic Article
|
Targeting pathogenic postischemic self-recognition by natural IgM to protect against posttransplantation cardiac reperfusion injury.
|
Academic Article
|
Early Application of Auxiliary Partial Orthotopic Liver Transplantation in Murine Model of Wilson Disease.
|
Academic Article
|
Prevention of Defective Placentation and Pregnancy Loss by Blocking Innate Immune Pathways in a Syngeneic Model of Placental Insufficiency.
|
Academic Article
|
Complementing regeneration.
|
Academic Article
|
Thromboembolic Model of Cerebral Ischemia and Reperfusion in Mice.
|
Academic Article
|
Surface Expression of TGF? Docking Receptor GARP Promotes Oncogenesis and Immune Tolerance in Breast Cancer.
|
Academic Article
|
Natural immunoglobulin M initiates an inflammatory response important for both hepatic ischemia reperfusion injury and regeneration in mice.
|
Academic Article
|
Natural IgM antibodies that bind neoepitopes exposed as a result of spinal cord injury , drive secondary injury by activating complement.
|
Academic Article
|
Targeted Complement Inhibition Protects Vascularized Composite Allografts From Acute Graft Injury and Prolongs Graft Survival When Combined With Subtherapeutic Cyclosporine A Therapy.
|
Academic Article
|
Aberrant JMJD3 Expression Upregulates Slug to Promote Migration, Invasion, and Stem Cell-Like Behaviors in Hepatocellular Carcinoma.
|
Academic Article
|
Injury site-specific targeting of complement inhibitors for treating stroke.
|
Academic Article
|
New Insights on Complement Inhibitor CD59 in Mouse Laser-Induced Choroidal Neovascularization: Mislocalization After Injury and Targeted Delivery for Protein Replacement.
|
Academic Article
|
Preclinical and Clinical Evidence on Ipsilateral Corticospinal Projections: Implication for Motor Recovery.
|
Academic Article
|
Identifying the Role of Complement in Triggering Neuroinflammation after Traumatic Brain Injury.
|
Academic Article
|
C3a receptor antagonism as a novel therapeutic target for chronic rhinosinusitis.
|
Academic Article
|
Targeted complement inhibition salvages stressed neurons and inhibits neuroinflammation after stroke in mice.
|
Academic Article
|
Acute Complement Inhibition Potentiates Neurorehabilitation and Enhances tPA-Mediated Neuroprotection.
|
Academic Article
|
Pharmacological Stimulation of Mitochondrial Biogenesis Using the Food and Drug Administration-Approved ?2-Adrenoreceptor Agonist Formoterol for the Treatment of Spinal Cord Injury.
|
Academic Article
|
Sialic acid is a critical fetal defense against maternal complement attack.
|
Academic Article
|
Complement C3a and C5a receptors promote GVHD by suppressing mitophagy in recipient dendritic cells.
|
Academic Article
|
Acid sphingomyelinase deficiency protects mitochondria and improves function recovery after brain injury.
|
Academic Article
|
CBX8 exhibits oncogenic properties and serves as a prognostic factor in hepatocellular carcinoma.
|
Academic Article
|
Inhibition of the alternative complement pathway accelerates repair processes in the murine model of choroidal neovascularization.
|
Academic Article
|
Complement C3 activation regulates the production of tRNA-derived fragments Gly-tRFs and promotes alcohol-induced liver injury and steatosis.
|
Academic Article
|
Complement C3-Targeted Gene Therapy Restricts Onset and Progression of Neurodegeneration in Chronic Mouse Glaucoma.
|
Academic Article
|
Targeting the Complement Alternative Pathway Permits Graft Versus Leukemia Activity while Preventing Graft Versus Host Disease.
|
Academic Article
|
Anti-inflammatory and Neuroprotective Agents in Clinical Trials for CNS Disease and Injury: Where Do We Go From Here?
|
Academic Article
|
C2 IgM Natural Antibody Enhances Inflammation and Its Use in the Recombinant Single Chain Antibody-Fused Complement Inhibitor C2-Crry to Target Therapeutics to Joints Attenuates Arthritis in Mice.
|
Academic Article
|
Complement Drives Synaptic Degeneration and Progressive Cognitive Decline in the Chronic Phase after Traumatic Brain Injury.
|
Academic Article
|
Complement-Mediated Microglial Phagocytosis and Pathological Changes in the Development and Degeneration of the Visual System.
|
Academic Article
|
A novel injury site-natural antibody targeted complement inhibitor protects against lung transplant injury.
|
Academic Article
|
Natural immunoglobulin M-based delivery of a complement alternative pathway inhibitor in mouse models of retinal degeneration.
|
Academic Article
|
Complement mediates neuroinflammation and cognitive decline at extended chronic time points after traumatic brain injury.
|
Academic Article
|
Complement-Dependent Synaptic Uptake and Cognitive Decline after Stroke and Reperfusion Therapy.
|
Academic Article
|
Chronic complement dysregulation drives neuroinflammation after traumatic brain injury: a transcriptomic study.
|
Academic Article
|
In Situ Pre-Treatment of Vascularized Composite Allografts With a Targeted Complement Inhibitor Protects Against Brain Death and Ischemia Reperfusion Induced Injuries.
|
Academic Article
|
Modulation of the Complement System by Neoplastic Disease of the Central Nervous System.
|
Academic Article
|
Increasing the efficacy and safety of a human complement inhibitor for treating post-transplant cardiac ischemia reperfusion injury by targeting to a graft-specific neoepitope.
|
Academic Article
|
Characterization of Novel P-Selectin Targeted Complement Inhibitors in Murine Models of Hindlimb Injury and Transplantation.
|
Academic Article
|
Complement Inhibition Alleviates Cholestatic Liver Injury Through Mediating Macrophage Infiltration and Function in Mice.
|
Academic Article
|
A Role of Complement in the Pathogenic Sequelae of Mouse Neonatal Germinal Matrix Hemorrhage.
|
Academic Article
|
Crosstalk between pro-survival sphingolipid metabolism and complement signaling induces inflammasome-mediated tumor metastasis.
|